Template:Peripheral neuropathy: Difference between revisions
Jump to navigation
Jump to search
Saumya Easaw (talk | contribs) No edit summary |
No edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
| colspan="1" style="text-align:center; background:DarkGray" | | | colspan="1" style="text-align:center; background:DarkGray" | | ||
Peripheral neuropathy Microchapters | '''Peripheral neuropathy Microchapters''' | ||
|- bgcolor="LightGrey" | |- bgcolor="LightGrey" | ||
! | ! | ||
| Line 27: | Line 27: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Peripheral neuropathy classification|Classification]] | [[Peripheral neuropathy classification|Classification]] | ||
|- | |- | ||
| Line 45: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Peripheral neuropathy differential diagnosis|Differentiating | [[Peripheral neuropathy differential diagnosis|Differentiating peripheral neuropathy from other Diseases]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Peripheral neuropathy epidemiology and demographics|Epidemiology and Demographics]] | |||
|- | |- | ||
! | ! | ||
| Line 51: | Line 57: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Peripheral neuropathy | [[Peripheral neuropathy risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
| Line 57: | Line 63: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Peripheral neuropathy | [[Peripheral neuropathy screening|Screening]] | ||
|- | |- | ||
! | ! | ||
| Line 70: | Line 76: | ||
! | ! | ||
Diagnosis | Diagnosis | ||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Peripheral neuropathy diagnostic study of choice|Diagnostic Study of Choice]] | |||
|- | |- | ||
! | ! | ||
| Line 93: | Line 105: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Peripheral neuropathy CT|CT]] | [[Peripheral neuropathy electrocardiogram|Electrocardiogram]] | ||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Peripheral neuropathy x ray|X-ray]] | |||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Peripheral neuropathy echocardiography and ultrasound|Echocardiography and Ultrasound]] | |||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Peripheral neuropathy CT scan|CT scan]] | |||
|- | |- | ||
! | ! | ||
| Line 124: | Line 154: | ||
! | ! | ||
[[Peripheral neuropathy medical therapy|Medical Therapy]] | [[Peripheral neuropathy medical therapy|Medical Therapy]] | ||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Peripheral neuropathy interventions|Interventions]] | |||
|- | |- | ||
! | ! | ||
| Line 137: | Line 173: | ||
[[Peripheral neuropathy primary prevention|Primary Prevention]] | [[Peripheral neuropathy primary prevention|Primary Prevention]] | ||
|- | |- | ||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | ! | ||
[[Peripheral neuropathy secondary prevention|Secondary Prevention]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
| Line 149: | Line 191: | ||
[[Peripheral neuropathy future or investigational therapies|Future or Investigational Therapies]] | [[Peripheral neuropathy future or investigational therapies|Future or Investigational Therapies]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="CadetBlue" | |- bgcolor="CadetBlue" | ||
| Line 201: | Line 243: | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://images.google.com/images?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab= | [http://images.google.com/images?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wi Images] | ||
|- | |- | ||
! | ! | ||
| Line 236: | Line 278: | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://google2.fda.gov/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&x=0&y=0&client=FDA&site=FDA&lr=&proxystylesheet=FDA&output=xml_no_dtd&getfields=* FDA on{{PAGENAME}}] | [http://google2.fda.gov/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&x=0&y=0&client=FDA&site=FDA&lr=&proxystylesheet=FDA&output=xml_no_dtd&getfields=* FDA on {{PAGENAME}}] | ||
|- | |- | ||
! | ! | ||
| Line 248: | Line 290: | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://news.google.com/news?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wn{{PAGENAME}} in the news] | [http://news.google.com/news?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wn {{PAGENAME}} in the news] | ||
|- | |- | ||
! | ! | ||
| Line 260: | Line 302: | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+ | [http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Psoriasis}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating Psoriasis] | ||
|- | |- | ||
! | ! | ||
Latest revision as of 14:32, 15 August 2018
|
Peripheral neuropathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Peripheral neuropathy On the Web |
|
American Roentgen Ray Society Images of Peripheral neuropathy |